Free press releases distribution network?

Agency / Source: inGenious Targeting Laboratory, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



inGenious Targeting Laboratory, Inc. Announces New Headqueaters - inGenious Targeting Laboratory's larger, state-of-the-art headquarters will provide provide iTL with new opportunities as iTL continues to define itself as a leader in the custom mouse model industry - Genetargeting.com
inGenious Targeting Laboratory, Inc. Announces New Headqueaters

 

PRZOOM - /newswire/ - Ronkonkoma, NY, United States, 2012/01/31 - inGenious Targeting Laboratory's larger, state-of-the-art headquarters will provide provide iTL with new opportunities as iTL continues to define itself as a leader in the custom mouse model industry - Genetargeting.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

inGenious Targeting Laboratory (iTL), a leader in the industry of genetically modified mice, announces the relocation of their world headquarters to a new facility in Ronkonkoma, NY. The move, in response to an expanding staff and increasing technical demands, will allow iTL to provide its employees with additional space and tools to address their client’s evolving research needs.
“The new laboratory will provide iTL with the room to accommodate an increasing client base. It will also give us the capacity to broaden the scope of the technology used to address new, and potential challenges in the strategy design and execution of customized gene targeted mouse models,” said iTL’s President and COO Paul Sheiffele. “We are delighted to move into this new space, and are excited to be a part of the growing life science community in the area.”

The new headquarters, located at 2200 Smithtown Ave, Ronkonkoma, NY is surrounded by world-class research facilities such as, Stony Brook University, Cold Spring Harbor and Brookhaven National Laboratory; institutions which iTL has shared long-standing relationships with.

About inGenious Targeting Laboratory (iTL)

inGenious Targeting Laboratory, Inc. (genetargeting.com) was founded in 1998, and is a global provider of gene targeting and custom mouse model production and services. iTL has delivered over eleven hundred successful custom mouse models to investigators worldwide. iTL is dedicated exclusively to the generation of customized gene targeted mouse models for the research community including researchers in academic and medical institutes, government research centers, and pharmaceutical and biotechnology companies. Clients retain full intellectual property rights to their projects. A full range of project capabilities are available including conventional knockout, conditional knockout, knockin, reporter genes, knockin human/murine cDNAs, targeted transgenic models, as well as novel approaches for custom models. Full-service customer projects are initiated immediately upon completion of design parameters and progress to completion on-site.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: inGenious Targeting Laboratory, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


inGenious Targeting Laboratory, Inc. Announces New Headqueaters

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Tegan Ryan - GeneTargeting.com 
631-681-5653 marketing[.]genetargeting.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any inGenious Targeting Laboratory, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From inGenious Targeting Laboratory, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  K A C, Images and U, LLC

Visit  Triggr & Bloom

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today